September 1st is World Chronic Lymphocytic Leukaemia (CLL) Day, the most common leukaemia in adults. Most patients with CLL respond well to treatment1
The Committee for the Evaluation of Medicinal Products for Human Use of the Spanish Agency of Medicines and Medical Devices (AEMPS) has approved ARI01
This year, FERO will contribute €200,000, with which it will seek to provide structural and sustained support for the Molecular Diagnostics Programme1
Researchers at the Clínic-IDIBAPS coordinated a study published in Blood Cancer Journal in which a new 3D system was developed from patient samples t1
A study published recently in the journal Clinical Cancer Research identified biomarkers that can predict the response to CAR T-cell therapy targetin1
The BBVA Foundation – Hospital Clínic de Barcelona Advanced Research Contracts are aimed at specialists in the Health Sciences, with experience in re1
The Hospital Clínic Barcelona has presented the documentary ARI. "A story of love and lif", which tells the story of Ariana Benedé, Ari, and how a gr1
An international team, co-led by the Hospital Clínic-IDIBAPS, has identified four biomarkers that determine the risk of the recurrence of this cancer1
The hospital stands out with five services in first place: Digestive System, General and Digestive Surgery, Haematology, Nephrology, and Radiodiagno1
There are still many questions surrounding lymphoma, its differences with leukemia and, above all, its treatment.
